Back to Work with Peptides
These late August days have been busy for us as we’ve been attending two peptide conferences. We started by attending the Peptide Therapeutics Forum 2024 at the Biozentrum Basel. Immediately following, we participated in the 37th European Peptide Symposium & 14th International Peptide Symposium in Florence.
Gate2Brain has a strong connection to this event, as our CEO, Meritxell Teixido , served as Chair for the 2022 edition of these symposiums, which took place in Sitges, Barcelona.
We were at the heart of the biannual conference where the entire peptide research community gathers, with over 1,000 attendees. The conference featured talks from major pharmaceutical companies, biotech firms, and academics.
It was a highly active Symposium, during which our CEO served as co-moderator for the session “Innovation in Peptide Chemistry”, gave a talk in the “Peptide Delivery and Materials” series titled “Gate2Brain Blood-Brain Barrier Shuttle Peptides: From Discovery to Applications and Going Beyond Small Molecules”, and a workshop in the “Navigating entrepreneurship and technology transfer in peptide discovery and development” series titled “Gate2Brain entrepreneurial journey towards patients”.
Nobel Laureate Morten Meldal: Insights on Click Chemistry
We had the honor of attending an inspiring keynote lecture by Nobel Laureate Morten Meldal, who shared insights from his groundbreaking work. His contributions to chemistry, particularly in the development of click chemistry, have had a profound impact on the field, a technique that Gate2Brain incorporates into its G2B-002 product.
Attending the Josef Rudinger Memorial Award 2024 Ceremony
At the Josef Rudinger Memorial Award 2024 ceremony, we celebrated the prestigious award recipients, Professor Fernando Albericio and Professor David Andreu . This award recognizes their significant career contributions and is one of the highest honors in the field.
For us, it was a deeply emotional moment, as Professor Andreu was the Master’s thesis advisor for our CEO, Meritxell Teixido , and Professor Albericio, along with Ernest Giralt , were PhD advisors for both Meritxell and Gloria Sanclimens Pérez de Rozas, Gate2Brain ’s COO. Additionally, Ernest Giralt and Fernando Albericio, pivotal figures in the global peptide field, are members of Gate2Brain ’s External Advisory Board and serve as Key Opinion Leaders (KOLs) for us.
Fernando Albericio, a Research Professor at the University of KwaZulu-Natal and Emeritus Professor of Organic Chemistry at UB, is renowned for his work in peptide synthesis and environmentally friendly solid-phase peptide synthesis processes. David Andreu is Professor of Chemistry emeritus at Universitat Pompeu Fabra and head of the Protein Chemistry and Proteomics Laboratory, has made notable advancements in bioactive peptides, proteomics, glycomics, and mass spectrometry.
gate2brain
G2B
